Transforming the Treatment of GI Diseases
Protecting Intestinal Barrier Health
Transforming the Treatment
of GI Diseases
Precision Delivery for Patient-Tailored Therapies that Protect Intestinal Integrity
Our mission is to identify, develop and commercialize novel therapeutics that target diseases resulting from a loss of gastrointestinal barrier integrity.
Science
Targeting Inflammatory Bowel Disease (IBD) Including Crohn’s Disease and Ulcerative Colitis
We are advancing a proprietary targeted prodrug platform to address the two most common forms of inflammatory bowel disease (IBD), ulcerative colitis and Crohn’s disease.
Science
Targeting Inflammatory Bowel Disease (IBD) Including Crohn’s Disease and Ulcerative
We are advancing a proprietary targeted prodrug platform to address the two most common forms of inflammatory bowel disease (IBD), ulcerative colitis and Crohn’s disease.
Our Pipeline
DISCOVERY
Pre-Clinical
Phase 1
Phase 2
Phase 3
Ulcerative Colitis
Preclinical
Fibro Stenotic
Crohn’s Disease
Crohn’s Disease
Discovery
Palisade Bio Investor Relations
Important Events
[jsoncontentimporterpro nameoftemplate=”Events” param1=0]
[jsoncontentimporterpro nameoftemplate=”Events” param1=1]
[jsoncontentimporterpro nameoftemplate=”Events” param1=2]